Compliant CSF Flow Diverter for Chiari I Pressure Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Chiari I malformation, such as craniovertebral decompression, often result in complications and do not effectively address the underlying issue of increased cyclic pressure waves in cerebrospinal fluid (CSF) flow, which can lead to spinal cord cysts and other neurological issues.
Innovation Solution
An implantable, biocompatible device that adjusts its volume in response to CSF pressure changes, diverting spinal fluid flow from the foramen magnum and damping cyclic pressure pulsations, using a combination of passive and active compliant members to modulate CSF flow and pressure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If craniovertebral decompression is performed to enlarge the foramen magnum, then CSF flow is improved and pressure gradients are reduced, but surgical complications such as vertebral artery injury, spinal cord injury, and infection occur
Solution Approach 1:
The patent introduces a compliant chamber as an intermediary device placed in the cranial vault that indirectly affects CSF flow dynamics without requiring direct surgical alteration of the foramen magnum. This mediator absorbs pressure fluctuations and modifies flow patterns, achieving therapeutic effects while avoiding the direct surgical risks associated with craniovertebral decompression
Solution Approach 2:
The patent replaces the mechanical surgical intervention (bone removal and structural alteration) with a compliant mechanical device that passively responds to pressure changes. The compliant chamber uses material compliance and geometric design to achieve pressure modulation without the need for invasive skeletal surgery, thereby eliminating associated surgical complications
2Quantity of substance
If conventional CSF shunting is used to remove fluid, then some fluid accumulation is relieved, but the underlying increased cyclic pressure wave amplitude is not addressed and complications occur
Solution Approach 1:
The patent converts the harmful increased cyclic pressure waves into a beneficial therapeutic mechanism by using the pressure fluctuations themselves to drive the compliant chamber's volume changes. The chamber expands during high-pressure phases and contracts during low-pressure phases, actively utilizing the pathological pressure dynamics to achieve flow diversion and damping effects
Solution Approach 2:
The patent changes the physical parameters of the CSF system by introducing a compliant element that dynamically alters chamber volume in response to pressure changes. This parameter change enables the system to modulate flow rates and pressure gradients adaptively, addressing the root cause of the disease rather than merely removing fluid
3Reliability
If an implantable device with active compliant members is used to modulate CSF pressure, then CSF flow and pressure gradients are effectively controlled, but device complexity increases
Solution Approach 1:
The compliant chamber is designed to function autonomously without requiring external power sources or control systems. The device self-regulates by utilizing the inherent elasticity of compliant materials and the natural pressure-difference-driven flow to expand and contract, thereby modulating CSF dynamics through passive, self-powered operation
Solution Approach 2:
The patent employs flexible compliant materials and thin-walled chamber structures that inherently respond to pressure changes through elastic deformation. This use of flexible shells eliminates the need for complex mechanical actuators, sensors, or control systems, achieving pressure modulation through the natural mechanical properties of the materials themselves
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device effectively reduces CSF flow and pressure gradients, potentially alleviating symptoms associated with Chiari I malformation by diverting fluid and reducing the amplitude of cyclic pressure waves, thereby diminishing the formation of spinal cord cysts and improving patient comfort.
Implementation Method 1
The disclosed invention consists of an implantable, biocompatible, and Magnetic Resonance (MR) compatible device... that functions as a chamber that effectively varies in size as CSF pressure changes, decreasing as CSF pressure increases and increasing as CSF pressure decreases, by utilizing passive compliant as well as active compliant members to modulated CSF pressure fluctuations
Implementation Method 2
Placed within the CSF fluid spaces of the cranial vault, the disclosed device, in various embodiments, effectively diverts spinal fluid flow from the foramen magnum and damps cyclic CSF pressure pulsations related to the cardiac cycle
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A device that can be placed within or near the cranial vault that fluctuates in size in response to changes in CSF pressure is disclosed. The device diminishes in size when CSF pressures rise and increases in size as CSF pressures diminish. The device has the effect of reducing the flow of CSF occurring in the foramen magnum and provides an alternative to craniovertebral decompression in Chiari I patients. The device may have applications in other neurologic illnesses associated with abnormal CSF flow, such as Idiopathic Syringomyelia, Normal Pressure Hydrocephalus, and CSF dural leaks.